Article Text

Download PDFPDF
Changing priorities for pulmonary fibrosis: the patient will see you now!
  1. Laura Fabbri1,2,
  2. Steve Jones3
  1. 1 Division of Respiratory Medicine, School of Medicine, University of Nottingham, Nottingham, UK
  2. 2 National Heart and Lung Institute, Imperial College London, London, UK
  3. 3 Action for Pulmonary Fibrosis, Peterborough, UK
  1. Correspondence to Dr Laura Fabbri, National Heart and Lung Institute, Imperial College London, London, SW3 6LY, UK; l.fabbri{at}imperial.ac.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Over the last century, the doctor–patient relationship has gradually evolved from a paternalistic to a more patient-centred approach, with a marked change in the last 20 years. This cultural shift is reflected in health research, where patients and the public have become increasingly engaged and empowered. The UK pioneered these changes, with patient and public involvement becoming, in 2006, a founding principle of the National Institute of Health Research (NIHR). The NIHR aims ‘to conduct leading edge research focussing on the needs of patients and the public’, with research being undertaken with or by members of the public, rather than on or to them.1 A basic premise is that involving lay people and bringing in different perspectives and experiences can improve research quality, while also empowering patients to influence change on issues they consider important. There are many different frameworks but one of the most useful is described by NIHR INVOLVE, the English national advisory group on public involvement, shown in table 1.2

View this table:
Table 1

Types of patient involvement

Some other frameworks consider ‘coproduction’ as the highest level, which means collaboration of researchers and patients throughout the research process—design, implementation and dissemination. A systematic review of patient and public involvement in Europe found more examples of …

View Full Text

Footnotes

  • Twitter @Istamina

  • Contributors LF and SJ contributed equally to this paper.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; externally peer reviewed.

Linked Articles